What Did EPCAT III Find? – Thrombosis Canada
Thrombosis Canada shared a post on LinkedIn:
”What did EPCAT III find?
In more than 5300 patients undergoing total hip or knee arthroplasty, symptomatic proximal DVT or pulmonary embolism occurred in:
- 0.48 percent of patients receiving aspirin alone
- 0.45 of patients receiving rivaroxaban for 5 days followed by aspirin
Aspirin alone met the trial’s prespecified criterion for noninferiority.
The findings provide important new evidence supporting aspirin alone as a thromboprophylaxis option after hip or knee arthroplasty in appropriately selected patients.
Patient selection remains important. Most participants in EPCAT III were classified as standard VTE risk, and patients with previous VTE or metastatic cancer were excluded.
In the latest CLOT Conversations, lead author Dr. Sudeep Shivakumar discusses the results with Dr.Jameel Abdulrehman and what they may mean for clinical practice.
More posts about Thrombosis CanadaThrombosis Canada on Hemostasis Today.
-
Oct 8, 2026, 17:00Sally Mandour: Platelet Size And Shape Can Reveal The Diagnosis
-
Oct 8, 2026, 16:49Neil Morgan: Advancing Understanding Of Bleeding Disorders Of Unknown Cause
-
Oct 8, 2026, 16:38Beverley Hunt: Advancing Pulmonary Embolism Care Through Collaboration And Learning
-
Oct 8, 2026, 16:19Cedric Hermans: Six Webinars Advancing Haemophilia Care And Beyond
-
Oct 8, 2026, 16:09Luana Banu: Every Donation Connects A Human Chain
-
Oct 8, 2026, 15:51Khaled Musallam: A New Era In Thalassemia Care
-
Oct 8, 2026, 15:40Juan J. Ortiz։ Catheter Directed Therapy In Pulmonary Embolism
-
Oct 8, 2026, 15:34Petros Kountouris: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 8, 2026, 15:14Renzo Mancuso: Human Stem Cell Model Reveals Progenitor Fate in Tissue Macrophages